SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-009889
Filing Date
2017-05-09
Accepted
2017-05-09 16:26:42
Documents
49
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q acad-10q_20170331.htm 10-Q 1203264
2 EX-10.1 acad-ex101_8.htm EX-10.1 12969
3 EX-10.2 acad-ex102_7.htm EX-10.2 34568
4 EX-31.1 acad-ex311_11.htm EX-31.1 9208
5 EX-31.2 acad-ex312_9.htm EX-31.2 9227
6 EX-32.1 acad-ex321_6.htm EX-32.1 6358
7 EX-32.2 acad-ex322_10.htm EX-32.2 6396
  Complete submission text file 0001564590-17-009889.txt   3582831

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT acad-20170331.xml EX-101.INS 666362
9 XBRL TAXONOMY EXTENSION SCHEMA acad-20170331.xsd EX-101.SCH 23894
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acad-20170331_cal.xml EX-101.CAL 38775
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acad-20170331_def.xml EX-101.DEF 44605
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20170331_lab.xml EX-101.LAB 187293
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20170331_pre.xml EX-101.PRE 135449
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 17826801
SIC: 2834 Pharmaceutical Preparations